G-NiiB GenieBiome’s leading technology in modifying the microbiome is driving health transformation for many human diseases
G-NiiB GenieBiome holds a comprehensive and unique databank for unlimited microbiome discoveries
“Transforming a human first, data-driven microbiome discovery platform to food and drug development for multiple diseases”
G-NiiB GenieBiome leverages one of the first and largest Asian human microbial data-driven approach to therapeutics development. Our expanding disease-specific microbial datasets compared with a comprehensive control microbial dataset provide a rich source for novel therapeutic candidates. We have the ability to develop novel consortia with beneficial functional and metabolic profiles, to target multiple human diseases.
If you are interested to join us in world-leading gut microbiome research and development, we'll help you find the right investment or partnership within our innovative platforms.
Read about our progress in exploring the gut microbiome and our latest partnerships to develop new health solutions.
.jpg)
